Your dollar valuation based on the management and BOD might be a bit rich, but the basis is spot on. Mars has done an exceptional job and directors Jervis Hough and Oleg Firer are great fits to help guide future growth. PSR of an industry average 4 puts the fair share value at 20-25 cents today, without factoring in potential.
RXMD does need to boost its PER, which it is taking steps to do.
Market Data 
Markets 
AI
